Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. announced the conversion of 7 bonds into 700,000 new shares by Global Growth Holding Limited, part of a convertible bond loan with warrants. This conversion increases Fidia’s share capital by Euro 70,000, bringing the total number of shares to 24,498,485. The move reflects Fidia’s strategic financial maneuvers to bolster its market position and enhance shareholder value.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.15 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on the Euronext Milan market, is a global leader in designing, producing, and marketing high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software for complex shapes.
Average Trading Volume: 781,545
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.34M
See more data about FDA stock on TipRanks’ Stock Analysis page.